Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic Patients
Clinical trial NCT01579812 · COMPLETED
Trial details
- NCT number
- NCT01579812
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2017-06-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.